These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37809010)

  • 1. Large variations in all-cause and overdose mortality among >13,000 patients in and out of opioid maintenance treatment in different settings: a comparative registry linkage study.
    Gabrhelík R; Hesse M; Nechanská B; Handal M; Mravčík V; Tjagvad C; Thylstrup B; Seid AK; Bukten A; Clausen T; Skurtveit S
    Front Public Health; 2023; 11():1179763. PubMed ID: 37809010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study.
    Eide D; Skurtveit S; Clausen T; Hesse M; Mravčík V; Nechanská B; Rolova G; Thylstrup B; Tjagvad C; Seid AK; Odsbu I; Gabrhelík R
    Eur Addict Res; 2023; 29(4):272-284. PubMed ID: 37385232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme.
    Tjagvad C; Skurtveit S; Linnet K; Andersen LV; Christoffersen DJ; Clausen T
    Eur Addict Res; 2016; 22(5):249-58. PubMed ID: 27246839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study.
    Kimber J; Larney S; Hickman M; Randall D; Degenhardt L
    Lancet Psychiatry; 2015 Oct; 2(10):901-8. PubMed ID: 26384619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
    Lugoboni F; Zamboni L; Cibin M; Tamburin S;
    Eur Addict Res; 2019; 25(1):10-19. PubMed ID: 30625491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
    Sordo L; Barrio G; Bravo MJ; Indave BI; Degenhardt L; Wiessing L; Ferri M; Pastor-Barriuso R
    BMJ; 2017 Apr; 357():j1550. PubMed ID: 28446428
    [No Abstract]   [Full Text] [Related]  

  • 7. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.
    Bukten A; Herskedal A; Skurtveit S; Bramness JG; Clausen T
    Addiction; 2013 Nov; 108(11):1954-61. PubMed ID: 23773400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications.
    Muller AE; Bjørnestad R; Clausen T
    Drug Alcohol Depend; 2018 Jun; 187():22-28. PubMed ID: 29626742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study.
    Clausen T; Anchersen K; Waal H
    Drug Alcohol Depend; 2008 Apr; 94(1-3):151-7. PubMed ID: 18155364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
    Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.
    Skurtveit S; Nechanská B; Handal M; Mahic M; Mravčík V; Gabrhelík R
    Addiction; 2019 Jul; 114(7):1225-1235. PubMed ID: 30725515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
    Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
    Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
    Kelty E; Hulse G
    Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study.
    Abrahamsson T; Berge J; Öjehagen A; Håkansson A
    Drug Alcohol Depend; 2017 May; 174():58-64. PubMed ID: 28315808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who receives heroin-assisted treatment? A comparison of patients receiving opioid maintenance treatment in Denmark.
    Melis F; Hesse M; Eide D; Thylstrup B; Tjagvad C; Brummer JE; Clausen T
    Drug Alcohol Depend; 2024 Jan; 254():111051. PubMed ID: 38091901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.
    Dunn KE; Finan PH; Andrew Tompkins D; Strain EC
    Addict Behav; 2018 Jan; 76():8-14. PubMed ID: 28735039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
    Reimer J; Vogelmann T; Trümper D; Scherbaum N
    Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.
    Gomes T; McCormack D; Bozinoff N; Tadrous M; Antoniou T; Munro C; Campbell T; Paterson JM; Mamdani M; Sproule B
    Addiction; 2022 Jul; 117(7):1972-1981. PubMed ID: 35257434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.